Insmed basks in the success of its lung disease drug — and prepares for what’s next CEO Will Lewis isn’t making promises, but now has strong results to build on

https://www.statnews.com/2026/01/12/jpm-conference-insmed-brinsupri-bronchiectasis/ By Adam FeuersteinJan. 12, 2026 Adam Feuerstein, a senior writer and biotech columnist, is the author of Adam’s Biotech Scorecard, a subscriber-only newsletter about the crossroads of drug development, business, Wall Street, and biotechnology.